期刊文献+

RP-HPLC法测定人血浆中盐酸多柔比星的浓度 被引量:4

Determination of Doxorubicin Hydrochloride Concentration in Human Plasma by RP-HPLC
原文传递
导出
摘要 目的:建立反相高效液相色谱法测定人血浆中盐酸多柔比星浓度的方法。方法:色谱柱为TianheKromasilC18,流动相为甲醇-0·01mol·L-1磷酸二氢铵溶液-冰醋酸(30:20:0·1),检测波长为233nm,流速为1·0mL·min-1,进样量为20μL,柱温为35℃,内标为柔红霉素。结果:盐酸多柔比星血药浓度在0·25~20·16μg·mL-1范围内与峰面积呈良好的线性关系(r=0·9996);平均方法回收率为96·45%(RSD=2·16%)。结论:本方法简便可行、重现性好,结果准确可靠,可用于临床患者血药浓度监测。 OBJECTIVE:To establish an RP-HPLC method for the determination of doxorubicin hydrochloride concentration in human plasma, METHODS: Tianhe Kromasil C18 was used as column, A solution of methenol -0.01 mol·L^-1 ammonium dihydrogen phosphate-acetic acid(30 : 20 : 0.1) was used as the mobile phase at a flow rate of 1.0 mL·min^-1.The detection of wavelength was set at 233 nm,The sample size was 20μL and the column temperature was 35℃ .The internal standard was daunorubiein. RESULTS: The calibration curve was linear in the range from 0.25-20.16 μg·mL^-1(r = 0.999 6) ;the average methodological recovery was 96.45% (RSD = 2.16% ) .CONCLUSIONS: The method is rapid, accurate, reproducible and easy to use in clinical detection of blood concentration.
出处 《中国药房》 CAS CSCD 北大核心 2008年第8期598-600,共3页 China Pharmacy
关键词 反相高效液相色谱法 盐酸多柔比星 血药浓度 RP-HPLC Doxorubiein hydroehlorid Blood concentration
  • 相关文献

参考文献4

二级参考文献13

  • 1侯梅,余萍,仲渝民,董昱,陈益.阿霉素不同剂量静脉注射的药动学及其临床意义[J].中国药房,1995,6(6):25-26. 被引量:3
  • 21,Grrrn RF, Collins JM, Jenkins JF,et al. Plasma pharmacokinetics of Adriamycin and adriamycinol implications for the desing of in vitro experiments and treatment protocols [J]. Cancer Res, 1983,43:3417
  • 32,Speth PAJ, Linssen PCM, Holderinet RSG,et al. Plasma and cellular adriamycin concentrations in patients nith myeloma treated with ninety-six-hour continuous infusion [J].Clin Pharnacol Therap, 1987,41:661
  • 43,Stallard S, Morrisor JG, George WD,et al. Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy [J]. Cancer Chemother Pharmacol, 1990,25:286.
  • 55, Gasparini G, Toffoli G, Berlanda G,et al. A pharmacological rationale for neoadjurant chemotherapy with adriamycin in locally advanced reast cancer [J]. Anticancer Res, 1990, 10:193
  • 6Buehler PW, Robles SJ, Adami GR, et al. Analysis of doxorubicin in cell culture media and human plasma using solid phase extraction and HPLC[J]. Chromatographia. 1999,49(9/10) :557.
  • 7Chan KK, Wong CD. Quantitative thin-layer chromatography:Thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue [ J ]. J Chromatogr B, 1979,172: 343.
  • 8Piall E, Aherne G W, Markes V. Evaluation of a commercially available radioimmunoassay part for measurement of doxorubicin in plasma[J]. Clin Chem, 1982,28: 119.
  • 9Laubrock N, Hempel G, Schulze-Westhoff P, et al. The stability of doxorubicin and Idarubicin in plasma and whole blood [ J].Chromatographia, 2000,52 ( 1/2 ): 9.
  • 10Caihong M, Neil G, Kasi SS, et al. Simultaneous quantitation of plasma doxorubicin and Prochlorperazine content by high performance liquid chromatography [ J ]. J Chromatogr B, 1997,703:217.

共引文献25

同被引文献29

  • 1Nair RR,Blake P,Grigorenko AN,et al.Fine Structure Constant Defines Visual Transparency of Graphene[J].Science,2008,320 (5881):1308.
  • 2van Vlerken LE,Amiji MM. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery [J]. Exp Opin Drug Del,2006,3(2): 205-216.
  • 3Novoselov KS,Jiang Z,Zhang Y,et al. Room-temperature quantum hall effect in graphene[J]. Science,2007,315(5817): 1379-1382.
  • 4Hummers S. William,Richard E. Offeman. Preparation of Graphitic Oxide [J].J Am Chem Soc,1958,80(6): 1339-1339.
  • 5Zhang LM,Xia JG,Zhao QH,et al. Functional graphene oxide as s nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs[J]. Small,2010,6(4):537-544.
  • 6Zhang K,Ang BT,Zhang LL,et al. Pyrolyzed graphene oxide/resorcinol-formaldehyde resin composites as high-performance supercapacitor electrodes[J]. J Mat Chem,2011,21(8): 2663-2670.
  • 7Wilson R,Spiller D G,Beckett A,et al. Highly stable dextran-coated quantum dots for biomolecular detection and cellular imaging. Chem Mat,2010,22(23):6361-6369.
  • 8Leakakos T,Chen J,Lawson G,et al. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers [J]. Cancer Chem Pharmacol,2003,51(6): 445-450.
  • 9何茗芳,周晓艳,徐琳洁.盐酸多柔比星致Ⅲ度手-足综合征1例[J].全科护理,2009,7(35):3283-3284. 被引量:4
  • 10王晓丹,周宁琳,汪炜燕,汤毅达,章峻,莫宏,沈健.羧基化氧化石墨烯-镧复合物抗凝血性能的研究[J].功能材料,2011,42(1):104-107. 被引量:8

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部